Joon Lee
Stock Analyst at Truist Securities
(4.89)
# 52
Out of 5,148 analysts
115
Total ratings
67.54%
Success rate
51.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Buy | $500 → $700 | $330.59 | +111.74% | 8 | Feb 20, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $190.46 | +20.76% | 4 | Jan 12, 2026 | |
| ARGX argenx SE | Maintains: Buy | $950 → $1,030 | $756.76 | +36.11% | 14 | Jan 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $80 → $100 | $59.74 | +67.39% | 4 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $36 → $50 | $13.85 | +261.01% | 4 | Dec 15, 2025 | |
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $30.25 | +81.82% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $15.44 | -9.33% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $23.02 | +290.96% | 1 | Nov 5, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $28.37 | +55.09% | 1 | Sep 16, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $486.03 | +0.82% | 4 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $86 | $66.37 | +29.58% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $95 → $75 | $33.34 | +124.96% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $13.39 | +56.83% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $35.97 | +317.01% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $166.38 | +20.21% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $60.77 | +97.47% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $5.23 | +244.17% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.20 | +158.06% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $23.88 | +50.75% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.15 | +272.09% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $7.21 | +135.78% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.53 | +10.38% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.15 | +333.73% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $1.30 | +21,438.46% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $54.91 | -38.08% | 1 | Mar 16, 2021 |
Praxis Precision Medicines
Feb 20, 2026
Maintains: Buy
Price Target: $500 → $700
Current: $330.59
Upside: +111.74%
Jazz Pharmaceuticals
Jan 12, 2026
Maintains: Buy
Price Target: $220 → $230
Current: $190.46
Upside: +20.76%
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $950 → $1,030
Current: $756.76
Upside: +36.11%
BioMarin Pharmaceutical
Dec 23, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $59.74
Upside: +67.39%
Wave Life Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $36 → $50
Current: $13.85
Upside: +261.01%
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $30.25
Upside: +81.82%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $15.44
Upside: -9.33%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $23.02
Upside: +290.96%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $28.37
Upside: +55.09%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $486.03
Upside: +0.82%
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $66.37
Upside: +29.58%
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $33.34
Upside: +124.96%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $13.39
Upside: +56.83%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $35.97
Upside: +317.01%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $166.38
Upside: +20.21%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $60.77
Upside: +97.47%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $5.23
Upside: +244.17%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $6.20
Upside: +158.06%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $23.88
Upside: +50.75%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.15
Upside: +272.09%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.21
Upside: +135.78%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.53
Upside: +10.38%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $4.15
Upside: +333.73%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $1.30
Upside: +21,438.46%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $54.91
Upside: -38.08%